Identify both offered coagulants
Record PAC and alum product identities, forms and concentration reporting bases.
A trade description and price per tonne cannot establish equivalent treatment value.
Normalize before screening
Keep elemental aluminum or Al2O3-equivalent additions explicit and show conversions.
A normalized comparison structures the test but does not prove equal performance.
Measure the changed chemical environment
Record initial alkalinity and final pH, including any feasible correction.
An uncontrolled pH difference can make an apparent product comparison misleading.
Compare the complete treatment
Match water, temperature, mixing and separation with an incumbent reference.
Use the relevant water, residual, sludge and filter measurements rather than floc size alone.
Make an application-specific award
Calculate delivered cost at the dose that met the agreed outcome and include justified handling differences.
Keep the tested identity, field-confirmation status and process limitations attached to the order.
Carry the treatment evidence into purchasing
Keep water analysis, product identity, preparation, final pH, mixing and separation results attached to the buying decision. Resolve the relevant next questions with PAC vs Ferric Coagulant Quotes: Compare Water, pH and Solids Cost; Liquid PAC Quotes: Compare 10% and 18% Al2O3 Offers.
A technically accepted candidate still needs an identifiable supply scope, current product documents and a feasible delivery and receiving plan. Record any conditions still pending. Changes in formulation, water source, production state or treatment equipment should trigger review rather than automatically inherit an earlier approval.
Compare the complete treatment cost
Compare PAC and alum only after choosing one chemical basis. Product tonnes, solution percentages and supplier dose numbers are not directly comparable. Convert both candidates to a declared active aluminum or Al2O3 basis, keep the same raw-water batch and document the conversion. Include the current plant product as a reference because an unfamiliar laboratory method can otherwise favor either chemistry unfairly.
Build matched dose ladders and record pH and alkalinity before and after treatment. PAC and alum can consume alkalinity and shift pH differently, so a turbidity comparison made at uncontrolled final pH may actually compare two different coagulation environments. If pH adjustment is part of normal operation, evaluate the chemical demand and the operational complexity together with clarification performance.
Measure the complete treatment result: floc formation, settled turbidity, color or organics where relevant, residual aluminum, sludge volume, dewatering behavior and downstream filter run. Faster visible floc is useful only when the final water and solids consequences remain acceptable. Repeat the leading conditions rather than selecting from one isolated jar.
The commercial comparison should include delivered active chemical cost, storage, dilution or dissolution, feed equipment, alkalinity correction, dose stability, sludge handling and any effect on filtration. The defensible conclusion is not that one coagulant is universally superior. It is that one candidate produced the stronger overall operating window in the tested water and process, subject to a controlled plant trial.
Confirm the comparison during a representative operating period before replacing the incumbent. Keep feed concentration, calibration, flow pacing and sampling frequency visible to both operations and the laboratory. If the preferred chemistry changes sludge production or filter loading, allow enough trial time to observe that consequence. Record the boundary conditions that would cause the plant to return to the incumbent or repeat testing.